$Sonnet BioTherapeutics(SONN.US) still needs a risk warning
This stock previously surged to $20 because it was to be used as a shell for crypto stock
After the merger it accounts for 1% following HYBE
Based on the merger value the average per share is $3.3 With this trading volume and turnover rate it's hard not to suspect market manipulation
Last time too many people got trapped and had to cut losses







